BIOMAT Database Logo BIOMAT Database Logo

[Experimental studies on the mechanism of thrombocyte aggregation inhibition caused by sulfonylurea compounds. 2. Modification of blood sugar and thrombocyte aggregation by oral antidiabetics]. 1975

W Losert, and A Hoder, and C Scholz

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D010973 Platelet Adhesiveness The process whereby PLATELETS adhere to something other than platelets, e.g., COLLAGEN; BASEMENT MEMBRANE; MICROFIBRILS; or other "foreign" surfaces. Adhesiveness, Platelet,Adhesivenesses, Platelet,Platelet Adhesivenesses
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002271 Carbutamide A sulfonylurea antidiabetic agent with similar actions and uses to CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277) Aminophenurobutane,Butylcarbamide,Glybutamide,Sulfaninylbutylurea,Bucarban,Bukarban,Diabetal,Glucidoral,Oranil,Oranyl
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005905 Glyburide An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide Glibenclamide,Daonil,Diabeta,Euglucon 5,Euglucon N,Glybenclamide,HB-419,HB-420,Maninil,Micronase,Neogluconin,HB 419,HB 420,HB419,HB420

Related Publications

W Losert, and A Hoder, and C Scholz
[Modification of the blood-sugar-lowering effect of oral antidiabetics by other drugs].
April 1973, Das Deutsche Gesundheitswesen,
W Losert, and A Hoder, and C Scholz
[EXPERIMENTAL STUDIES ON THE MECHANISM OF ACTION OF SULFONYLUREA COMPOUNDS].
August 1963, Endokrinologie,
W Losert, and A Hoder, and C Scholz
Inhibition of 3H-glibenclamide binding to sulfonylurea receptors by oral antidiabetics.
January 1985, Arzneimittel-Forschung,
W Losert, and A Hoder, and C Scholz
[Drug information. Agents for the treatment of diabetes mellitus (antidiabetics). Therapeutic main group: oral antidiabetics. 2. Sulfonylurea compounds].
August 1977, Sygeplejersken,
W Losert, and A Hoder, and C Scholz
[Mechanism of action of oral antidiabetics; sulfonylurea and pituitary-adrenal system].
July 1957, Helvetica medica acta,
W Losert, and A Hoder, and C Scholz
[Suicide by means of oral antidiabetics (sulfonylurea products)].
April 1966, Munchener medizinische Wochenschrift (1950),
W Losert, and A Hoder, and C Scholz
Inhibition of thrombocyte aggregation by oral motapizone and other drugs.
January 1986, European journal of clinical pharmacology,
W Losert, and A Hoder, and C Scholz
[The chemotherapeutic use of antidiabetics. Sulfonylurea compounds and glinides].
January 2002, Pharmazie in unserer Zeit,
W Losert, and A Hoder, and C Scholz
[Model studies and new aspects on the mechanism of thrombocyte aggregation].
March 1969, Blut,
W Losert, and A Hoder, and C Scholz
[Drug information: Agents for the treatment of diabetes mellitus (antidiabetics). Therapeutic main group: oral antidiabetics--sulfonylurea compounds. 3].
September 1977, Sygeplejersken,
Copied contents to your clipboard!